158 related articles for article (PubMed ID: 23412167)
1. Prevention of early bone loss around the prosthesis by administration of anti-osteoporotic agents and influences of collared and non-collared femoral stem prostheses on early periprosthetic bone loss.
Ji WP; Wang XL; Ma MQ; Lan J; Li H
Eur J Orthop Surg Traumatol; 2013 Jul; 23(5):565-71. PubMed ID: 23412167
[TBL] [Abstract][Full Text] [Related]
2. Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial.
Morita A; Kobayashi N; Choe H; Ike H; Tezuka T; Higashihira S; Inaba Y
J Orthop Surg Res; 2020 Jan; 15(1):17. PubMed ID: 31948455
[TBL] [Abstract][Full Text] [Related]
3. Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty.
Arabmotlagh M; Pilz M; Warzecha J; Rauschmann M
J Orthop Res; 2009 Feb; 27(2):183-8. PubMed ID: 18752281
[TBL] [Abstract][Full Text] [Related]
4. Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty.
Nagoya S; Tateda K; Okazaki S; Kosukegawa I; Shimizu J; Yamashita T
Eur J Orthop Surg Traumatol; 2018 Dec; 28(8):1601-1607. PubMed ID: 29774416
[TBL] [Abstract][Full Text] [Related]
5. Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss.
Rahmy AI; Gosens T; Blake GM; Tonino A; Fogelman I
Osteoporos Int; 2004 Apr; 15(4):281-9. PubMed ID: 14661072
[TBL] [Abstract][Full Text] [Related]
6. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.
Arabmotlagh M; Rittmeister M; Hennigs T
J Orthop Res; 2006 Jul; 24(7):1336-41. PubMed ID: 16705719
[TBL] [Abstract][Full Text] [Related]
7. The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.
Sköldenberg OG; Salemyr MO; Bodén HS; Ahl TE; Adolphson PY
J Bone Joint Surg Am; 2011 Oct; 93(20):1857-64. PubMed ID: 22012522
[TBL] [Abstract][Full Text] [Related]
8. Short to Midterm Follow-Up of Periprosthetic Bone Mineral Density after Total Hip Arthroplasty with the Ribbed Anatomic Stem.
Wu XD; Tian M; He Y; Chen H; Chen Y; Mishra R; Liu W; Huang W
Biomed Res Int; 2019; 2019():3085258. PubMed ID: 31346514
[TBL] [Abstract][Full Text] [Related]
9. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients.
Tapaninen TS; Venesmaa PK; Jurvelin JS; Miettinen HJ; Kröger HP
Scand J Surg; 2010; 99(1):32-7. PubMed ID: 20501356
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Alendronate for the Prevention of Bone Loss in Calcar Region Following Total Hip Arthroplasty.
Yukizawa Y; Inaba Y; Kobayashi N; Choe H; Kubota S; Saito T
J Arthroplasty; 2017 Jul; 32(7):2176-2180. PubMed ID: 28318867
[TBL] [Abstract][Full Text] [Related]
11. Stem length in primary cementless total hip arthroplasty: Does it make a difference in bone remodeling?
Samy AM; El-Tantawy A
Eur J Orthop Surg Traumatol; 2019 Aug; 29(6):1235-1242. PubMed ID: 30989339
[TBL] [Abstract][Full Text] [Related]
12. Periprosthetic Bone Mineral Density Around Uncemented Titanium Stems in the Second and Third Decade After Total Hip Arthroplasty: A DXA Study After 12, 17 and 21 Years.
Peitgen DS; Innmann MM; Merle C; Gotterbarm T; Moradi B; Streit MR
Calcif Tissue Int; 2018 Oct; 103(4):372-379. PubMed ID: 29858615
[TBL] [Abstract][Full Text] [Related]
13. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
Zhou W; Liu Y; Guo X; Yang H; Xu Y; Geng D
Osteoporos Int; 2019 Aug; 30(8):1581-1589. PubMed ID: 31115592
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density as a marker of hip implant longevity: a prospective assessment of a cementless stem with dual-energy X-ray absorptiometry at twenty years.
Sessa G; Costarella L; Puma Pagliarello C; Di Stefano A; Sessa A; Testa G; Pavone V
Int Orthop; 2019 Jan; 43(1):71-75. PubMed ID: 30284002
[TBL] [Abstract][Full Text] [Related]
15. Is there a significant decrease in the femoral cortical bone around Furlong
Cruz E; Natera L; Mitjans M; Antón C; Cañete E; Cases E
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):117-122. PubMed ID: 31468186
[TBL] [Abstract][Full Text] [Related]
16. Stem anteversion affects periprosthetic bone mineral density after total hip arthroplasty.
Hayashi S; Hashimoto S; Kanzaki N; Kuroda R; Kurosaka M
Hip Int; 2016 May; 26(3):260-4. PubMed ID: 27102558
[TBL] [Abstract][Full Text] [Related]
17. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study.
Venesmaa PK; Kröger HP; Miettinen HJ; Jurvelin JS; Suomalainen OT; Alhav EM
J Bone Miner Res; 2001 Nov; 16(11):2126-31. PubMed ID: 11697810
[TBL] [Abstract][Full Text] [Related]
18. The effect of simvastatin on periprosthetic bone mineral density in the hypercholesterolaemic patients after total hip arthroplasty.
Zhang X; Sun Y; Xie H; Liu J; Zhao Y; Xu Z
Int Orthop; 2018 Jan; 42(1):59-64. PubMed ID: 28681228
[TBL] [Abstract][Full Text] [Related]
19. Fixation of the fully hydroxyapatite-coated Corail stem implanted due to femoral neck fracture: 38 patients followed for 2 years with RSA and DEXA.
Schewelov Tv; Ahlborg H; Sanzén L; Besjakov J; Carlsson A
Acta Orthop; 2012 Apr; 83(2):153-8. PubMed ID: 22112154
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of bisphosphonate intervention on periprosthetic BMD as a function of stem design.
Knusten AR; Ebramzadeh E; Longjohn DB; Sangiorgio SN
J Arthroplasty; 2014 Jun; 29(6):1292-7. PubMed ID: 24703781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
